Advanced Tapping Technology for Gen 3 and Gen 4 Systems Delivers “Calibration-Free” Operation
SAN JOSE, Calif., March 01, 2017 -- SerialTek, a worldwide provider of ground-breaking SAS/SATA and PCIe/NVMe protocol analysis products today announced the availability of calibration-free, ultra-low-loss interposers for use in analyzing current- and next-generation PCIe signals. Using current industry approaches, users of PCIe/NVMe protocol analyzers spend hours calibrating test equipment to establish an initial, error-free link under test. Using this innovative interposer technology coupled with the new PCIe Micro II analyzer platform, users can now set up SerialTek PCIe/NVMe protocol analyzers and capture traces in just minutes.
“PCIe analyzer calibration can consume significant time and effort,” said Ross Stenfort, Director of Solution Architecture, CNEX Labs. “The availability of a calibration-free PCIe/NVMe protocol analyzer will increase productivity and greatly decrease time to market.” Mario Pasquali, a SerialTek board member, stated “this is a fantastic achievement for the engineering team. I am looking forward to the innovations that will come from this pool of talent. The combination of zero calibration and auto-archiving gives us the first truly plug and play NVMe analyzer.”
Availability
The SerialTek x4 slot-based interposer is available immediately (PE-1SLI1-0403-000 for Gen 3 and PE-1SLI1-0404-000 for Gen 4). Interposers with U.2 (both 1x4/2x2) or M.2 (host) are planned for availability by the end of Q1. Immediate solutions also available for x4 slot/U.2 device/dual slot 2x2 (U.2) and M.2 device. For more information, including photos, please visit the following URL or contact your local authorized SerialTek sales channel partner. Upgrades to existing SerialTek PCIe Micro analyzers to take advantage of this new interposer technology are available immediately.
https://www.serialtek.com/pcie-interposers-taps.php
Gen 4 Ready
The new interposers are PCIe Gen 4 ready, and as such are ideal for protecting customers' investments to next-generation PCIe technology. Customers can purchase the Gen 4 interposer today and will have a Gen 4 interposer ready when upgrading their SerialTek analyzer to Gen 4.
About SerialTek
Established in 2007, SerialTek LLC is a provider of advanced test and analysis tools for data storage technologies. Leading storage manufacturers depend on SerialTek products to improve product quality and drive time-to-market requirements. Solutions include Serial Attached SCSI (SAS), SATA (Serial ATA), PCI Express (PCIe) and Non-Volatile Memory Express (NVMe) protocols.
For further information about the SerialTek products, visit www.serialtek.com.
SerialTek and the SerialTek logo are registered trademarks of SerialTek LLC, and may be registered in some jurisdictions. Other trademarks and trade names are those of their respective owners.
Media Contact: Paul Mutschler, CEO, SerialTek LLC Tel: +1 303-810-5110 Email: [email protected]


Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Want to cut your energy bills? Here’s how five experts are doing it
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
John Ternus Signals Apple’s Future with Product-First AI Strategy 



